Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2020 | May 05, 2021 | Jun. 30, 2020 | |
Registrant Name | AMERICAN REBEL HOLDINGS INC | ||
Registrant CIK | 0001648087 | ||
Fiscal Year End | --12-31 | ||
Document Type | 10-K/A | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2020 | ||
Document Transition Report | false | ||
Entity File Number | 000-55728 | ||
Entity Incorporation, State or Country Code | NV | ||
Entity Tax Identification Number | 47-3892903 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 2,940,998.74 | ||
Entity Common Stock, Shares Outstanding | 79,466,563 | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2020 | ||
Document Fiscal Period Focus | FY | ||
Principal executive offices | |||
Entity Address, Address Line One | 718 Thompson Lane, Suite 108-199 | ||
Entity Address, City or Town | Nashville | ||
Entity Address, State or Province | TN | ||
Entity Address, Postal Zip Code | 37204 | ||
Entity Address, Address Description | Address of principal executive offices | ||
Phone Fax Number Description | Registrant’s telephone number, including area code | ||
City Area Code | 833 | ||
Local Phone Number | 267-3235 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 60,899 | $ 131,656 |
Accounts Receivable | 176,844 | 228,890 |
Prepaid expense | 48,640 | 542,800 |
Inventory | 681,709 | 805,845 |
Inventory deposits | 141,164 | 91,641 |
Total Current Assets | 1,109,256 | 1,800,832 |
Property and Equipment, net | 5,266 | 66,990 |
OTHER ASSETS: | ||
Lease Deposit | 6,841 | 6,841 |
Investment | 0 | 0 |
Total Other Assets | 6,841 | 6,841 |
TOTAL ASSETS | 1,121,363 | 1,874,663 |
CURRENT LIABILITIES: | ||
Accounts payable and accrued expense | 540,168 | 684,126 |
Accrued Interest - Convertible Debenture - Related Party | 603,471 | 303,860 |
Loan - Officer - Related party | 4,526 | 4,496 |
Loan - Working Capital | 4,672,096 | 3,595,561 |
Loans - Nonrelated parties | 15,649 | 25,746 |
Total Current Liabilities | 5,835,910 | 4,613,789 |
Convertible Debenture -Related party | 297,890 | 207,890 |
TOTAL LIABILITIES | 6,133,800 | 4,821,679 |
STOCKHOLDERS' EQUITY (DEFICIT): | ||
Preferred Stock, Value | 0 | 0 |
Common Stock, Value | 72,808 | 43,062 |
Additional paid in capital | 15,785,468 | 11,899,553 |
Accumulated deficit | (20,870,713) | (14,889,631) |
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) | (5,012,437) | (2,947,016) |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ 1,121,363 | $ 1,874,663 |
CONSOLIDATED BALANCE SHEETS - P
CONSOLIDATED BALANCE SHEETS - Parenthetical - $ / shares | Dec. 31, 2020 | Dec. 31, 2019 |
Details | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Shares Authorized | 1,000,000 | 1,000,000 |
Preferred Stock, Shares Issued | 0 | 0 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Common Stock, Shares, Issued | 72,807,979 | 43,062,058 |
Common Stock, Shares, Outstanding | 72,807,979 | 43,062,058 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Details | ||
Revenue | $ 1,255,703 | $ 535,109 |
Cost of goods sold | 952,511 | 379,076 |
Gross margin | 303,192 | 156,033 |
Expenses: | ||
Consulting - business development | 529,094 | 3,809,291 |
Product development costs | 320,472 | 309,061 |
Marketing and brand development costs | 390,294 | 632,522 |
Administrative and other | 1,773,529 | 1,343,352 |
Depreciation expense | 61,724 | 62,028 |
Operating Expenses | 3,075,113 | 6,156,254 |
Operating income (loss) | (2,771,921) | (6,000,221) |
Other Income (Expense) | ||
Interest expense | (2,292,957) | (1,601,851) |
Net income (loss) before income tax provision | (5,981,082) | (7,602,072) |
Provision for income tax | 0 | 0 |
Loss on Extinguishment of Debt | (916,204) | 0 |
Net income (loss) | $ (5,981,082) | $ (7,602,072) |
Basic and diluted income (loss) per share | $ (0.10) | $ (0.25) |
Weighted average common shares outstanding - basic and diluted | 61,109,000 | 33,541,000 |
CONSOLIDATED STATEMENT OF STOCK
CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT - USD ($) | Common Stock | Additional Paid-in Capital | Retained Earnings | Total |
Equity Balance, Starting at Dec. 31, 2015 | $ 13,455 | $ 1,100,295 | $ (979,511) | $ 134,239 |
Shares Outstanding, Starting at Dec. 31, 2015 | 13,455,000 | |||
Stock Issued During Period, Value, New Issues | $ 1,166 | 581,834 | 0 | 583,000 |
Stock Issued During Period, Shares, New Issues | 1,166,000 | |||
Net Income (Loss) | $ 0 | 0 | (1,363,506) | (1,363,506) |
Shares Outstanding, Ending at Dec. 31, 2016 | 14,621,000 | |||
Equity Balance, Ending at Dec. 31, 2016 | $ 14,621 | 1,682,129 | (2,343,017) | (646,267) |
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | $ 3,150 | 1,571,850 | 0 | 1,575,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 3,150,000 | |||
Reverse Acquisition of American Rebel, Inc, Value | $ 6,000 | (231,032) | 0 | (225,032) |
Reverse Acquisition of American Rebel, Inc, Shares | 6,000,000 | |||
Net Income (Loss) | $ 0 | 0 | (2,942,838) | (2,942,838) |
Shares Outstanding, Ending at Dec. 31, 2017 | 23,771,000 | |||
Equity Balance, Ending at Dec. 31, 2017 | $ 23,771 | 3,022,947 | (5,285,855) | (2,239,137) |
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | $ 800 | 429,200 | 0 | 430,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 800,000 | |||
Convertible Debenture Discount | $ 0 | 270,000 | 0 | 270,000 |
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ 4,681 | 2,335,848 | 0 | 2,340,529 |
Stock Issued During Period, Shares, Conversion of Convertible Securities | 4,681,058 | |||
Stock Issued During Period, Value, Stock Options Exercised | $ 660 | 329,340 | 0 | 330,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 660,000 | |||
Net Income (Loss) | $ 0 | 0 | (2,001,704) | (2,001,704) |
Shares Outstanding, Ending at Dec. 31, 2018 | 29,912,058 | |||
Equity Balance, Ending at Dec. 31, 2018 | $ 29,912 | 6,387,336 | (7,287,559) | (870,312) |
Stock Issued During Period, Value, New Issues | $ 100 | 900 | 0 | 1,000 |
Stock Issued During Period, Shares, New Issues | 100,000 | |||
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | $ 13,050 | 5,344,950 | 0 | 5,358,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 13,050,000 | |||
Convertible Debenture Discount | $ 0 | 166,368 | 0 | $ 166,368 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 250,000 | |||
Net Income (Loss) | $ 0 | 0 | (7,602,072) | $ (7,602,072) |
Shares Outstanding, Ending at Dec. 31, 2019 | 43,062,058 | |||
Equity Balance, Ending at Dec. 31, 2019 | $ 43,062 | 11,899,553 | (14,889,631) | (2,947,016) |
Stock Issued During Period, Value, New Issues | 0 | |||
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | $ 29,746 | 3,885,915 | 0 | 3,915,661 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 29,745,921 | |||
Net Income (Loss) | $ 0 | 0 | (5,981,082) | (5,981,082) |
Shares Outstanding, Ending at Dec. 31, 2020 | 72,807,979 | |||
Equity Balance, Ending at Dec. 31, 2020 | $ 72,808 | $ 15,785,468 | $ (20,870,713) | $ (5,012,437) |
CONSOLIDATED STATEMENT OF CASH
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
CASH FLOW FROM OPERATING ACTIVITIES: | ||
Net income (loss) | $ (5,981,082) | $ (7,602,072) |
Depreciation | 61,724 | 62,028 |
Compensation paid through issuance of common stock | 2,786,931 | 3,486,500 |
Amortization of loan discount | 708,975 | 2,014,784 |
Adjustments to reconcile net loss to cash (used in) operating activities: | ||
Change in Accounts Receivable | 54,938 | (229,166) |
Change in prepaid expenses | 254,160 | (425,500) |
Change in inventory | 124,137 | (36,961) |
Change in inventory deposits | (49,524) | (91,640) |
Change in accounts payable and accrued expense | 65,102 | 643,413 |
Net Cash (Used in) Operating Activities | (1,974,639) | (2,178,614) |
Net Cash (Used in) Investing Activities | 0 | 0 |
CASH FLOW FROM INVESTING ACTIVITIES: | ||
Property and equipment purchased | 0 | 0 |
CASH FLOW FROM FINANCING ACTIVITIES: | ||
Proceeds from sale of common stock | 0 | 3,500 |
Proceeds (repayments) of loans - officer - related party | 51,083 | (12,092) |
Proceeds of working capital loan | 2,869,171 | 2,474,560 |
Repayment of loans - nonrelated party | (1,016,372) | (175,329) |
Net Cash Provided by Financing Activities | 1,903,882 | 2,290,639 |
CHANGE IN CASH | (70,757) | 112,025 |
Cash and Cash Equivalents, at Carrying Value, Beginning Balance | 131,656 | 19,631 |
Cash and Cash Equivalents, at Carrying Value, Ending Balance | 60,899 | 131,656 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||
Interest | 168,834 | 45,565 |
Income taxes | 0 | 0 |
Non-cash investing and financing activities: | ||
Conversion of Debentures to common stock | $ 0 | $ 0 |
Note 1 - Summary of Significant
Note 1 - Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 1 - Summary of Significant Accounting Policies | NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization The “Company” was incorporated on December 15, 2014 (date of inception) under the laws of the State of Nevada, as CubeScape, Inc. Effective January 5, 2017, the Company amended its articles of incorporation and changed its name to American Rebel Holdings, Inc. The Company completed a business combination with its majority stockholder, American Rebel, Inc. on June 19, 2017. As a result, American Rebel, Inc. became a wholly owned subsidiary of the Company. The acquisition of American Rebel, Inc. was accounted for as a reverse merger. The Company issued 17,421,000 shares of its common stock and issued warrants to purchase 500,000 shares of common stock to shareholders of American Rebel, Inc. and cancelled 9,000,000 shares of common stock owned by American Rebel, Inc. The Company filed a registration statement on Form S-1 which was declared effective by the U.S. Securities and Exchange Commission on October 14, 2015. Twenty six (26) investors invested at a price of $0.01 per share for a total of $60,000. The direct public offering closed on December 11, 2015. Nature of operations The Company is developing branded products in the self-defense, safe storage and patriotic product areas that are promoted and sold using personal appearance, music, internet and television avenues. The Company’s products will be under the American Rebel Brand and imprinted. Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and its majority-owned subsidiary. All significant intercompany accounts and transactions have been eliminated. Year end The Company’s year-end is December 31. Cash and cash equivalents For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value. Inventory and Inventory Deposits Inventory consists of safes, backpacks, jackets and accessories manufactured to our design and held for resale and are carried at the lower of cost (First-in, First-out Method) or market value. The Company determines the estimate for the reserve for slow moving or obsolete inventories by regularly evaluating individual inventory levels, projected sales and current economic conditions. The Company also makes deposit payments on inventory to be manufactured that are carried separately until the goods are received into inventory. Fixed assets and depreciation Property and equipment are stated at cost net of accumulated depreciation. Additions and improvements are capitalized while ordinary maintenance and repair expenditures are charged to expense as incurred. Depreciation is recorded by the straight-line method over the estimated useful life of the asset, which ranges from five to seven years. Revenue recognition In accordance with ASC Topic 606, Revenue from Contracts with Customers ("ASC 606"), revenues are recognized when control of the promised goods or services is transferred to our clients, in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: 1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the company satisfies a performance obligation. We adopted this ASC on January 1, 2018. Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities within them. Advertising costs Advertising costs are expensed as incurred; Marketing costs incurred were $390,294 and $632,522 for the years ended December 31, 2020 and 2019, respectively. Fair value of financial instruments Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2020 and December 31, 2019, respectively. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, and accounts payable. Fair values were assumed to approximate carrying values for cash and payables because they are short-term in nature and their carrying amounts approximate fair values or they are payable on demand. Level 1: Level 2: FASB acknowledged that active markets for identical assets and liabilities are relatively uncommon and, even when they do exist, they may be too thin to provide reliable information. To deal with this shortage of direct data, the board provided a second level of inputs that can be applied in three situations. Level 3: If inputs from levels 1 and 2 are not available, the Financial Accounting Standards Board (the “FASB”) acknowledges that fair value measures of many assets and liabilities are less precise. The board describes Level 3 inputs as “unobservable,” and limits their use by saying they “shall be used to measure fair value to the extent that observable inputs are not available.” This category allows “for situations in which there is little, if any, market activity for the asset or liability at the measurement date”. Earlier in the standard, FASB explains that “observable inputs” are gathered from sources other than the reporting company and that they are expected to reflect assumptions made by market participants. Stock-based compensation The Company records stock-based compensation in accordance with the guidance in ASC Topic 505 and 718 which requires the Company to recognize expense related to the fair value of its employee stock option awards. This eliminates accounting for share-based compensation transactions using the intrinsic value and requires instead that such transactions be accounted for using a fair-value-based method. The Company recognizes the cost of all share-based awards on a graded vesting basis over the vesting period of the award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 718-10 and the conclusions reached by the FASB ASC 505-50. Costs are measured at the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by FASB ASC 505-50. In January 2018, the Company agreed to issue and subsequently issued a total of 500,000 shares of common stock as compensation for professional services to be performed during 2018. The common stock was valued at a price of $0.50 per share consistent with earlier sales of common stock by American Rebel, Inc. as well as the present conversion price of the Company’s convertible debentures. In January, 2018, the Company issued 300,000 shares of common stock as compensation in settlement of professional services billed at $180,000. During January 2018, the Company recorded $157,483 in compensation expense, increased prepaid expense $31,251, and reduced Accrued expense $74,600 with the issuance of 466,667 shares of common stock. The common stock was valued at prices of $0.50 and $0.60 per share consistent with earlier sales of common stock by American Rebel, Inc. as well as the present conversion price of the Company’s convertible debentures and negotiation with a vendor. During January 2019, the Company recorded $178,505 in compensation expense, increased prepaid expense $160,000, and increased Discount on debt $57,467 with the issuance of 400,000 shares of common stock and 175,000 warrants to purchase common stock. The common stock was valued at prices of $0.65 to $0.76 per share consistent with market prices at the date of the transaction. During September 2019, the Company recorded $3,432,000 in compensation expense and increased Discount on debt $819,500 with the issuance of 11,000,000 shares of common stock and 50,000 warrants to purchase common stock. The common stock was valued at prices of $0.70 to $0.30 per share consistent with market prices at the dates of the transactions. During October and November 2019, the Company recorded $330,000 in compensation expense and increased Discount on debt $86,000 with the issuance of 1,650,000 shares of common stock. The common stock was valued at prices of $0.22 to $0.30 per share consistent with market prices at the dates of the transactions. In February 2020, the Company issued 1,200,000 shares of its Common Stock to pay professional and consulting fees. Total fair value of $240,000 was recorded as an expense. In June 2020, the Company issued 810,000 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $95,000 was recorded as an expense. In August 2020, the Company issued 4,839,871 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $489,462 was recorded as an expense. In October 2020, the Company issued 6,410,000 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $553,820 was recorded as an expense. During May 2020, the Company issued 70,000 shares of its Common Stock in exchange for a debt reduction of $7,000. Earnings per share The Company follows ASC Topic 260 to account for earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. Income taxes The Company follows ASC Topic 740 for recording provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expense or benefit is based on the changes in the asset or liability for each period. If available evidence suggests that it is more likely than not that some portion or the entire deferred tax asset will not be realized, a valuation allowance is required to reduce the deferred tax asset to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income tax in the period of change. Deferred income tax may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC Topic 740 only allows the recognition of tax benefits that have a greater than fifty percent likelihood of being sustained upon examination by taxing authorities. As of December 31, 2020 and December 31, 2019, the Company reviewed its tax positions and determined there were no outstanding, or retroactive tax positions with less than a 50% likelihood of being sustained upon examination by the taxing authorities, therefore this standard has not had a material effect on the Company. The Company does not anticipate any significant changes to its total unrecognized tax benefits within the next 12 months. The Company classifies tax-related penalties and net interest as income tax expense. For the years ended December 31, 2020 and 2019, respectively, no income tax expense has been recorded. Use of estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates. Right of Use Assets and Lease Liabilities In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The standard requires lessees to recognize almost all leases on the balance sheet as a Right-of-Use (“ROU”) asset and a lease liability and requires leases to be classified as either an operating or a finance type lease. The standard excludes leases of intangible assets or inventory. The standard became effective for the Company beginning January 1, 2019. The Company adopted ASC 842 using the modified retrospective approach, by applying the new standard to all leases existing at the date of initial application. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under ASC 842, while prior period amounts have not been adjusted and continue to be reported in accordance with our historical accounting under ASC 840. The Company elected the package of practical expedients permitted under the standard, which also allowed the Company to carry forward historical lease classifications. The Company also elected the practical expedient related to treating lease and non-lease components as a single lease component for all equipment leases as well as electing a policy exclusion permitting leases with an original lease term of less than one year to be excluded from the ROU assets and lease liabilities. Under ASC 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company estimated the incremental borrowing rate in determining the present value of lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’ lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating leases are included in operating lease Right-of-Use assets and operating lease liabilities, current and non-current, on the Company's consolidated balance sheets. Recent pronouncements The Company evaluated recent accounting pronouncements through December 31, 2020 and believes that none have a material effect on the Company’s financial statements. Concentration Risk In 2020, the Company purchased a substantial portion (over 20%) of inventory from two third-party vendors. As of December 31, 2020, the net amount due to the vendors (accounts payable and accrued expense) was $0. In 2019, the Company purchased substantially all of inventory from one third-party vendor. As of December 31, 2019, the net amount due to the vendor (accounts payable and accrued expense) was $221,920. The loss of these manufacturing vendor relationships could have a material effect on the Company, but the Company believes there are numerous other suppliers that could be substituted should these suppliers become unavailable or non-competitive. |
Note 2 - Going Concern
Note 2 - Going Concern | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 2 - Going Concern | NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. As noted above, the Company is in the development stage and, accordingly, has not yet generated significant revenues from operations. Since inception, the Company has been engaged in financing activities and executing its business plan of operations and incurring costs and expenses related to developing products and market identity, obtaining inventory and preparing for public product launch. As a result, the Company incurred net income (losses) for the years ended December 31, 2020 and 2019 of ($5,981,082) and ($7,602,072), respectively. The Company’s accumulated deficit was ($20,870,713) as of December 31, 2020 and ($14,889,631) as of December 31, 2019. The Company’s working capital deficit was ($4,726,654) as of December 31, 2020 and a deficit of ($2,812,957) as of December 31, 2019. In addition, the Company’s development activities since inception have been sustained through equity and debt financing and the deferral of payments on accounts payable and other expenses. The ability of the Company to continue as a going concern is dependent upon its ability to raise capital from the sale of its equity and, ultimately, the achievement of operating revenues. Management believes holders of its warrants will execute their outstanding warrants generating investment capital for the Company. Management is also in discussion with several investment banks and broker dealers regarding the initiation of a capital campaign. Management believes sufficient funding can be secured through the obtaining of loans, as well as future offerings of its preferred and common stock to institutional and other financial sources. However, no assurance can be given that the Company will obtain this additional working capital, or if obtained, that such funding will not cause substantial dilution its stockholders. If the Company is unable to secure such additional funds from these sources, it may be forced to change or delay its business plan rollout. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. |
Note 3 - Inventory and Deposits
Note 3 - Inventory and Deposits | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 3 - Inventory and Deposits | NOTE 3 - INVENTORY AND DEPOSITS Inventory and deposits includes the following: December 31, December 31, 2020 2019 Inventory - Finished goods $ 681,709 $ 805,845 Inventory deposits 141,164 91,641 822,873 897,486 Less: Reserve for excess and obsolete - - Net inventory and deposits $ 822,873 $ 897,486 |
Note 4 - Property and Equipment
Note 4 - Property and Equipment | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 4 - Property and Equipment | NOTE 4 – PROPERTY AND EQUIPMENT Property and equipment includes the following: December 31, December 31, 2020 2019 Marketing equipment $ 32,261 $ 32,261 Vehicles 277,886 277,886 310,147 310,147 Less: Accumulated depreciation (304,881) (243,157) Net property and equipment $ 5,266 $ 66,990 For the years ended December 31, 2020 and 2019 we recognized $61,724 and $62,028 in depreciation expense, respectively. We depreciate these assets over a period of sixty (60) months which has been deemed their useful life. In January, 2016 we acquired three vehicles from related parties and assumed the debt secured by the vehicles as described at Note 7 – Notes Payable. Accordingly, the recorded cost of each vehicle is the amount of debt assumed under each related loan, or a total of $277,886. |
Note 5 - Related Party Note Pay
Note 5 - Related Party Note Payable and Related Party Transactions | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 5 - Related Party Note Payable and Related Party Transactions | NOTE 5 –RELATED PARTY NOTE PAYABLE AND RELATED PARTY TRANSACTIONS For the year ended December 31, 2016, the Company received loans from its sole officer and director at the time totaling $221,155. The balance at December 31, 2019 was $4,496. During the year ended December 31, 2020, the Company repaid $0 of these loans resulting in a balance at December 31, 2020 of $4,526. These loans are due on demand and carry no interest. During the year ended December 31, 2018, the Company entered into several convertible debt instruments with stockholders in the amount of $270,000, for a total of $345,000. The Company accrued interest expense on this convertible debt of $41,288, for a total of $113,178 at December 31, 2020. Since public trading of the Company’s common stock began in 2018, the Company determined a Beneficial Conversion Discount of $270,000 applied to the 2018 sales the Convertible Debentures. The discount reduced the liability balance of the debentures to $0 when the debentures were issued and recorded the proceeds of the sale as Additional paid in Capital. The discount will be amortized over the three year term of the debentures. The discounted balance of the convertible debentures at December 31, 2020 was $297,890. During the year ended December 31, 2016, the Company acquired three vehicles from various related parties and assumed the debt secured by each one of the vehicles. Accordingly, the recorded value for each vehicle is the total debt assumed under each related loan, or a total of $277,886. (See Note 7 – Notes Payable.) Charles A. Ross, Jr. serves as the Company’s CEO and director. Compensation for Mr. Ross was $180,250 and $200,000, respectively for the years ended December 31, 2020 and 2019. Mr. Ross received a grant of 1,000,000 shares of American Rebel, Inc. common stock, valued at $0.50 per share in June 2017, prior to the acquisition. These shares were part of the 6,500,000 shares that Mr. Ross exchanged for Company common stock in the acquisition of American Rebel, Inc. completed on June 19, 2017. In September 2019, Mr. Ross received a grant of 2,725,000 shares of common stock, valued at $0.30 per share. |
Note 6 - Notes Payable - Non-re
Note 6 - Notes Payable - Non-related Parties | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 6 - Notes Payable - Non-related Parties | NOTE 6 – NOTES PAYABLE – NONRELATED PARTIES Effective January 1, 2016, the Company acquired three vehicles from various related parties in exchange for the assumption of the liabilities related to those vehicles. The liabilities assumed are as follows at December 31, 2019 and December 31, 2018. December 31, December 31, 2020 2019 Loan secured by a tour bus, payable in monthly payments of $2,710 including interest at 12% per annum through July 2020 when the remaining balance is payable. $ 15,649 $ 25,746 Total recorded as current liability $ 15,649 $ 25,746 Current and long-term portion. Total loan balance is reported as current because loans are past due, become due within one year or are expected to be repaid within one year. |
Note 7 - Notes Payable - Workin
Note 7 - Notes Payable - Working Capital | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 7 - Notes Payable - Working Capital | NOTE 7 – NOTES PAYABLE – WORKING CAPITAL On July 6, 2017, the Company’s wholly-owned operating subsidiary completed the sale of a secured promissory note in the principal amount of $250,000 with an interest rate of 12% per annum to a private investor, and current stockholder. In April, 2018 the Company’s wholly-owned operating subsidiary completed the sale of additional notes under similar terms in the additional principal amount totaling $250,000. In July, 2018 the Company’s wholly-owned operating subsidiary completed the sale of additional notes under similar terms in the additional principal amount totaling $300,000. In October and December, 2018 the Company’s wholly-owned operating subsidiary completed the sale of additional notes under similar terms in the additional principal amount totaling $425,000. The notes are secured by a pledge of certain of the Company’s current inventory and the chief executive officer’s personal guaranty. These working capital notes require payments equal to 75-100% of current sales of that specific secured inventory and mature in 180 days. In connection with the original note, the Company issued 250,000 shares of its common stock to the noteholder valued at $0.50 per share for a total of $125,000. The fair value of the common stock issued was recorded as a discount to the note payable and the discount was amortized over the term of that agreement to interest expense using the straight-line method that approximates the effective interest method. During the year ending December 31, 2019, the Company and the Company’s wholly-owned operating subsidiary completed the sale of additional short term notes under similar terms in the additional principal amount totaling $3,104,441. The notes are secured by a pledge of certain of the Company’s current inventory and the chief executive officer’s personal guaranty. These short term working capital notes mature in 30-180 days. In connection with these notes, the Company issued 1,550,000 shares of its common stock, warrants to purchase 125,000 shares of its common stock and a conversion feature for 300,000 shares at $0.50 per share. The fair value of these share incentives was calculated to be $1,134,368. The fair value of the share incentives was recorded as a discount to the note payable and the discount was amortized over the term of those agreements to interest expense using the straight-line method that approximates the effective interest method. Interest expense recorded as a result of amortization of discount for the year ended December 31, 2019 is $1,068,784. During the year ending December 31, 2020, the Company and the Company’s wholly-owned operating subsidiary completed the sale of additional short term notes and extensions of short term notes under similar terms in the additional principal amount totaling $2,869,171. The notes are secured by a pledge of certain of the Company’s current inventory and the chief executive officer’s personal guaranty. These short term working capital notes mature in 30-180 days. In connection with these notes, the Company issued 17,275,871 shares of its common stock, warrants to purchase 2,550,000 shares of its common stock. The fair value of these share incentives was calculated to be $1,660,112. The fair value of the share incentives was recorded as a discount to the note payable and the discount was amortized over the term of those agreements to interest expense using the straight-line method that approximates the effective interest method. Interest expense recorded as a result of amortization of discount for the year ended December 31, 2020 is $1,411,203. During the year ended December 31, 2020, the Company and the Company’s wholly-owned operating subsidiary completed the conversion of short term notes with a face value of $1,080,000 and accrued interest to 9,700,000 shares of Common Stock with a fair value of $1,651,900, resulting in a Loss on Extinguishment of Debt of $916,204. As of December 31, 2020, and 2019, the outstanding balance due on the working capital notes was $4,672,096 and $3,595,561, respectively. NOTE PAYABLE SCHEDULE Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at December 31, 2020 Balance at December 31, 2019 Note Payable (a) $200,000 3/4/2018 12/31/2018 12% $200,000 $200,000 Note Payable (b) $7,000 1/9/2019 $9,073 $8,689 Note Payable (c) $400,000 11/1/2018 5/1/2019 12% $400,000 $400,000 Note Payable (d) $300,000 12/31/2018 12/31/2020 $300,000 Note Payable (e) $55,000 1/14/2019 3/15/2019 15% $30,000 $30,000 Note Payable (f) $150,000 3/1/2019 9/30/2019 20% $0 $0 Note Payable (g) $450,000 5/1/2019 5/1/2020 18% $0 $450,000 Note Payable (h) $180,000 7/5/2019 1/1/2020 18% $0 $180,000 Note Payable (i) $180,000 7/15/2019 1/11/2020 18% $0 $180,000 Note Payable (j) $225,000 8/22/2019 3/31/2020 $225,000 $165,000 Note Payable (k) $180,000 8/26/2019 2/22/2020 18% $0 $180,000 Note Payable (l) $180,000 9/5/2019 3/3/2020 18% $0 $180,000 Note Payable (m) $90,000 9/13/2019 3/11/2020 18% $0 $90,000 Note Payable (n) $180,000 9/13/2019 3/11/2020 18% $0 $180,000 Note Payable (o) $90,000 9/23/2019 3/21/2020 18% $0 $90,000 Note Payable (p) $150,000 9/30/2019 3/31/2020 20% $0 $150,000 Note Payable (q) $180,000 10/15/2019 4/12/2020 18% $95,000 $180,000 Note Payable (r) $180,000 11/5/2019 5/3/2020 18% $0 $180,000 Note Payable (s) $90,000 11/12/2019 5/10/2020 18% $0 $90,000 Note Payable (t) $100,000 11/19/2019 11/19/2020 18% $0 $50,000 Note Payable (u) $75,000 11/20/2019 5/20/2020 16% $0 $75,000 Note Payable (v) $455,670 12/17/2019 6/4/2022 12% $408,875 $455,670 Note Payable (w) $134,386 12/20/2019 $134,386 Note Payable (x) 12/31/2019 $12,219 $17,400 Note Payable (y) $201,000 1/30/2020 6/1/2020 12% $183,000 Note Payable (z) $125,000 1/31/2020 1/31/2021 7.5% $0 Note Payable (aa) $225,000 2/14/2020 1/14/2021 25% $18,750 Note Payable (ab) $90,000 2/18/2020 2/18/2021 18% $0 Note Payable (ac) $180,000 2/20/2020 2/20/2021 18% $0 Note Payable (ad) $200,000 3/6/2020 7/6/2021 12% $200,000 Note Payable (ae) $722,422 3/10/2020 2/8/2024 11.5% $679,609 Note Payable (af) $90,000 3/11/2020 9/11/2020 18% $0 Note Payable (ag) $300,000 3/26/2020 3/26/2021 6% $300,000 Note Payable (ah) $150,000 4/1/2020 10/1/2020 20% $0 Note Payable (ai) $8,000 4/15/2020 5/15/2021 $8,000 Note Payable (aj) $18,343 4/15/2020 5/15/2021 $18,343 Note Payable (ak) $180,000 4/25/2020 10/25/2020 18% $0 Note Payable (al) $450,000 5/1/2020 10/31/2020 18% $0 Note Payable (bn) $100,000 5/20/2020 11/20/2020 18% $0 Note Payable (am) $100,000 6/10/2020 12/10/2020 $100,000 Note Payable (an) $75,000 6/15/2020 6/15/2021 18% $75,000 Note Payable (ao) $101,000 6/18/2020 12/18/2020 $101,000 Note Payable (ap) $50,000 6/29/2020 9/29/2020 $0 Note Payable (aq) $102,000 7/3/2020 10/3/2020 $72,188 Note Payable (ar) $150,000 7/31/2020 7/31/2021 12% $0 Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at December 31, 2020 Balance at December 31, 2019 Note Payable (as) $150,000 8/5/2020 8/5/2021 12% $134,400 Note Payable (at) $350,000 9/3/2020 9/3/2021 12% $392,000 Note Payable (au) $100,000 9/10/2020 9/10/2021 12% $100,000 Note Payable (av) $250,000 10/1/2020 1/2/2021 8% $250,000 Note Payable (aw) $100,000 10/6/2020 10/6/2021 12% $100,000 Note Payable (ax) $200,000 10/13/2020 10/13/2021 12% $200,000 Note Payable (ay) $250,000 10/21/2020 4/21/2021 8% $250,000 Note Payable (az) $450,000 11/01/2020 4/30/2021 20% $450,000 Note Payable (ba) $150,000 11/1/2020 4/30/2021 20% $150,000 Note Payable (bb) $118,049 11/19/2020 11/19/2021 18% $118,049 Note Payable (bc) $109,200 11/20/2020 5/21/2021 18% $109,200 Note Payable (bd) $60,000 12/16/2020 12/16/2021 18% $60,000 Note Payable (be) $40,000 1/6/2021 1/7/2022 18% Note Payable (bf) $117,600 3/1/2021 4/21/2021 8% Note Payable (bg) $50,000 3/4/2021 3/4/2022 12% Note Payable (bh) $273,187 3/31/2021 12/1/2021 Note Payable (bi) $1,000,000 4/9/2021 10/6/2021 8% Note Payable (bj) $591,000 4/18/2021 9/1/2023 Note Payable (bk) $639,956 4/21/2021 4/22/2021 8% Note Payable (bl) $151,688 4/22/2021 5/1/2021 Note Payable (bm) $190,000 4/30/2021 10/30/2021 Unamortized Discount $(777,610) $(370,584) Total $4,672,096 $3,595,561 (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) (n) (o) (p) (q) (r) (s) (t) (u) (v) (w) (x) (y) (z) (aa) (ab) (ac) (ad) (ae) (af) (ag) (ah) (ai) (aj) (ak) (al) (am) (an) (ao) (ap) (aq) (ar) (as) (at) (au) (av) (aw) (ax) (ay) (az) (ba) (bb) (bc) (bd) (be) (bf) (bg) (bh) (bi) (bj) (bk) (bl) (bm) (bn) |
Note 8 - Convertible Debenture,
Note 8 - Convertible Debenture, Related Party | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 8 - Convertible Debenture, Related Party | NOTE 8- CONVERTIBLE DEBENTURE – RELATED PARTY Since September 16, 2016, the Company sold convertible debentures in the amount of $2,405,000 in the form of 12% three-year convertible term notes. Interest is accrued at an annual rate of 12% and is payable in common stock at maturity. Both principal and interest may be converted into common stock at a price of $0.50 per share after the passage of 181 days. The Company may redeem the debenture at its option or force conversion after common stock trades at a price in excess of $1.00 per share for five days. The Holder may force redemption after the Company raises $3 million dollars in equity. The holders of the convertible debentures were issued three year warrants to purchase 2,405,000 shares of the Company’s common stock at $1.00 per share. As of December 31, 2018, the Company received $2,405,000 under this convertible debenture. In April and November, 2018, debentures with face value of $2,060,000 plus accrued interest of $280,529 were converted into 4,681,058 shares of common stock. As of December 31, 2019, the Company had a face value of $345,000 due under this convertible debenture. The convertible debenture holder, based on its agreement, with maturities beginning September 16, 2019 has the option to convert their principal and interest into 690,000 (plus 60,980 for accrued interest) shares of common stock. The fair value of the embedded beneficial conversion feature resulted in a discount of $227,110 to the convertible debenture – related party at December 31, 2019 and a discount of $137,110 at December 31, 2020. During the year ended December 31, 2018, the Company sold convertible debt instruments in the amount of $270,000. Since public trading of the Company’s common stock began in 2018, the Company determined a beneficial conversion discount of $270,000 applied to the 2018 sales the convertible debt instruments. The discount reduced the liability balance of the debentures to $0 when the debentures were issued and recorded the proceeds of the sale as Additional paid in Capital. The discount will be amortized over the three year term of the debentures. The discounted balance of the convertible debentures at December 31, 2020 was $297,890. The Company analyzed the conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and fair value measurement under ASC 820 and determined that the beneficial conversion feature under the convertible debenture should be recorded as a discount to debt if market was more than the conversion feature. The convertible debenture - related party is measured at fair value at the end of each reporting period or termination of the debenture agreement with the change in fair value recorded to earnings. The fair value of the embedded beneficial conversion feature did not result in a discount to the convertible debenture - related party. The discount if and when we have one will be amortized over the term of agreement or modification to the agreement to interest expense using the straight-line method that approximates the effective interest method. The Company used the eight steps to determine fair value under ASC 820. (1) Identify the item to be valued and the unit of account. (2) Determine the principal or most advantageous market and the relevant market participants. (3) Select the valuation premise to be used for asset measurements. (4) Consider the risk assumptions applicable to liability measurements. (5) Identify available inputs. (6) Select the appropriate valuation technique(s). (7) Make the measurement. (8) Determine amounts to be recognized and information to be disclosed. Fair value was determined by the market price of the Company’s publicly traded stock with no discount allowed. This was determined as of the effective date of the agreement entered convertible debenture - related party. The conversion price was then compared to fair value, determined by market price and the difference between the two multiplied by the number of shares that would be issued upon conversion. The Company has not had any market activity within its public market. Private transactions between willing buyers and willing sellers have ranged from $0.02 to $0.50 per share. These transactions were not conducted through a broker-dealer network. Since public trading of the common stock began in 2018, market price of the Company’s traded stock has ranged from $0.05 to $2.50 per share. |
Note 9 - Embedded Derivatives -
Note 9 - Embedded Derivatives - Financial Instruments | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 9 - Embedded Derivatives - Financial Instruments | NOTE 9 – EMBEDDED DERIVATIVES – FINANCIAL INSTRUMENTS Since September 2016 the Company entered into a financial instrument, which consists of a convertible debenture, containing a conversion feature. Generally financial instruments are convertible into shares of the Company’s common stock; at prices that are either marked to the volume weighted average price of the Company’s publicly traded stock or a static price determinative from each financial instrument agreement. These prices may be at a significant discount to market as determined overall by the volume weighted average price of the Company’s publicly traded common stock. The Company for all intent and purposes considers these discounts to be fair market value as would be determined in an arm’s length transaction with a willing buyer and the restrictive nature of the common stock issued, unless issued pursuant to a registration or some other registered shares with the SEC. The Company accounts for the fair value of the conversion feature in accordance with ASC 815-15, Derivatives and Hedging; Embedded Derivatives The fair value of the conversion feature of the financial instrument as of December 31, 2018 was $0. The Company did not record any expense associated with the embedded derivatives at December 31, 2018. No embedded derivative expense was realized as there was no change in the conversion price. The conversion price for this financial instrument was $0.50 per share which is higher than market as there have been no sales of the Company’s common stock. |
Note 10 - Income Taxes
Note 10 - Income Taxes | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 10 - Income Taxes | NOTE 10 – INCOME TAXES At December 31, 2020 and December 31, 2019, the Company had a net operating loss carryforward of $20,870,713 and $14,889,631, respectively, which begins to expire in 2034. Components of net deferred tax asset, including a valuation allowance, are as follows: December 31, 2020 December 31, 2019, Deferred tax asset: Net operating loss carryforward $ 4,382,850 $ 3,126,823 Total deferred tax asset 4,382,850 3,126,823 Less: Valuation allowance (4,382,850) (3,126,823) Net deferred tax asset $ - $ - Valuation allowance for deferred tax assets as of December 31, 2020 and December 31, 2019 was $4,382,850 and $3,126,823, respectively. In assessing the recovery of the deferred tax asset, management considers whether it is more likely than not that some portion or the entire deferred tax asset will not be realized. The ultimate realization of the deferred tax asset is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax assets, projected future taxable income, and tax planning strategies in making this assessment. As a result, management determined it was more likely than not deferred tax assets will not be realized as of December 31, 2020 and December 31, 2019 and recognized 100% valuation allowance for each period. Reconciliation between statutory rate and the effective tax rate for and as of December 31, 2020 and 2019: Federal statutory rate (21.0)% State taxes, net of federal benefit (0.00)% Change in valuation allowance 21.0% Effective tax rate 0.0% |
Note 11 - Share Capital
Note 11 - Share Capital | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 11 - Share Capital | NOTE 11 – SHARE CAPITAL The Company is authorized to issue 100,000,000 shares of its $0.001 par value common stock and 1,000,000 shares of its $0.001 par value preferred stock. Common stock On December 15, 2014, the Company issued to its founder, then an officer and director of the Company, 6,000,000 shares of its $0.001 par value common stock at a price of $0.001 per share for services provided upon organization. The services were valued at $6,000. On January 15, 2015, the Company issued to its founder 3,000,000 shares of its $0.001 par value common stock at a price of $0.008 per share for certain intangible assets and tangible assets (see Note 3 - Intangible Assets). Mr. David Estus, then our sole officer and director, incurred more than $50,000 in developing or acquiring the intangible and tangible assets for which the Company valued at $24,000. The Company filed a registration statement on Form S-1 which was declared effective by the U.S. Securities and Exchange Commission on October 14, 2015. The Form S-1 allowed the Company to solicit investors for investment in a direct public offering of $60,000. Twenty six (26) investors invested at a price of $0.01 per share for the entire offering which closed on December 11, 2015. The Company issued 17,421,000 shares of its common stock and issued warrants to purchase 500,000 shares of common stock to shareholders of American Rebel, Inc. and cancelled 9,000,000 shares of common stock owned by American Rebel, Inc. to complete the acquisition of American Rebel, Inc. which was accounted for as a reverse merger. During June 2017, prior to the merger, American Rebel, Inc issued 2,800,000 shares of common stock as compensation and recorded an expense based on fair market value of $0.50 per share for a total expense of $1,400,000. On June 19, 2017, in connection with the merger and acquisition of the subsidiary, the Company exchanged 17,421,000 shares of common stock with stockholders of American Rebel, Inc. and cancelled 9,000,000 shares of common stock held by American Rebel, Inc. American Rebel, Inc. became a wholly owned subsidiary of the Company upon completion of the exchange. On July 6, 2017, the Company’s wholly-owned operating subsidiary completed the sale of a secured promissory note in the principal amount of $250,000 with an interest rate of 12% per annum to a private investor, and current stockholder. The note is secured by a pledge of all of the Company’s current inventory and the chief executive officer’s personal guaranty. This working capital note requires payments equal to 75% of current sales and matures in 180 days. In connection with this note, the Company issued 250,000 shares of its common stock to the noteholder. On August 6, 2017, the Company’s wholly-owned subsidiary completed an agreement to acquire a right to a trade show booth location early in 2018. In connection with this acquisition, the Company issued 100,000 shares of its common stock to the seller. In January 2018, the Company’s wholly owned subsidiary completed an agreement to acquire professional services during 2018 in exchange for 500,000 shares of the Company’s common stock. The common stock is to be issued in three stages, 166,667 shares in January 2018, 166,667 shares in May 2018 and the remainder in September 2018. The shares were valued at $.50 per share consistent with valuation of other share issues. In January 2018, the Company issued 300,000 shares of common stock to settle a liability for professional services billed in the amount of $180,000. In January 2019, the Company issued a 30 day warrant to purchase 250,000 shares of its common stock at a price of $0.01 per share to pay consulting fees. Total fair value of $160,000 was recorded as an expense of $160,000 at June 30, 2019. The warrants were exercised and 250,000 shares of common stock were issued. In January 2019, the Company’s wholly-owned operating subsidiary completed the sale of a secured promissory note in the principal amount of $300,000 with an interest rate of 16.66% per annum to a private investor. The note is secured by a pledge of all of the Company’s current inventory and the chief executive officer’s personal guaranty. This working capital note matures in 120 days. In connection with this note, the Company issued 100,000 shares of its common stock to the note holder. In May 2019, the Company identified 50,000 shares of common stock in its subsidiary that had been awarded at date of incorporation but not recorded by the Company. The share count was corrected to include these shares valued at Par value of $0.001. In September 2019, the Company issued 1,400,000 shares of its common stock in conjunction with notes payable and recorded loan discount of $812,000 based on fair market value of $0.30 and $0.95 per share. Of the loan discount recorded, the amount that had been amortized to interest expense at September 30, 2019 was $228,460. In September 2019, the Company issued 9,700,000 shares of its common stock to pay professional and consulting fees and recorded an expense based on fair market value of $0.30 and $0.95 per share for a total expense of $3,432,000, and recorded prepaid expense of $675,750. In November 2019, the Company issued 150,000 shares of its common stock in conjunction with notes payable and recorded loan discount of $86,000 based on fair market value of $0.30 and $0.22 per share. Of the loan discount recorded, the amount that had been amortized to interest expense at December 31, 2019 was $25,744. In December 2019, the Company issued 1,500,000 shares of its common stock to pay professional and consulting fees and recorded an expense based on fair market value of $0.22 per share for a total expense of $330,000. During the year ended December 31, 2020, the Company issued 17,275,871 shares of its Common Stock and issued five year warrants to sell 2,500,000 shares of common stock in connection with issue of short-term loans. The fair value of these share incentives was calculated to be $1,881,761 which was recorded as a discount to the notes payable and amortized to interest expense over the term of those loan agreements. Interest expense recorded as a result of amortization of discount for the year ended December 31, 2020 is $1,411,203. During the year ended December 31, 2020, the Company issued 9,700,000 shares of its Common Stock and completed the conversion of short-term notes with a face value of $1,080,000 and accrued interest. The fair value of these shares was calculated to be $1,651,900, resulting in a Loss on Extinguishment of Debt of $916,242. During the year ended December 31, 2020, the Company issued 2,700,000 shares of its Common Stock to pay professional and consulting fees. Total fair value of $375,000 was recorded as an expense. At December 31, 2020 and December 31, 2019, there were 72,807,979 and 43,062,058 shares of common stock issued and outstanding, respectively. |
Note 12 - Warrants and Options
Note 12 - Warrants and Options | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 12 - Warrants and Options | NOTE 12 – WARRANTS AND OPTIONS Since September 16, 2016, in connection with the convertible debenture –related party (see Note 8 – Convertible Debenture – Related Party) the Company issued three-year warrants to purchase 2,405,000 shares of the Company’s common stock at $1.00 per share. In conjunction with the conversion of convertible debt at April 30, 2018, the Company agreed to reduce the exercise price of the Warrants to $.50 per share. On June 19, 2017, the Company issued five-year warrants to purchase 500,000 shares of the Company’s common stock at $0.50 per share as compensation. In October 2020, the Company issued five-year warrants to purchase 2.500,000 shares of the Company’s common stock at $0.10 per share in connection with short term financing. In November 2020, the Company issued two-year warrants to purchase 50,000 shares of the Company’s common stock at $1.00 per share in connection with short term financing. As of December 31, 2018, there were 2,245,000 warrants issued and outstanding. As of December 31, 2020, there were 3,395,000 warrants outstanding to acquire additional shares of common stock. The Company evaluates outstanding warrants as derivative liabilities and will recognize any changes in the fair value through earnings. The Company determined that the Warrants have an immaterial fair value at December 31, 2020. The warrants do not trade in a highly active securities market, and as such, the Company estimated the fair value of these common stock equivalents using Black-Scholes and the following assumptions: Expected volatility was based primarily on historical volatility. Historical volatility was computed using daily pricing observations for recent periods. The Company’s common stock has not traded so the volatility computation was based on other similarly situated companies. The Company believes this method produced an estimate that was representative of the Company’s expectations of future volatility over the expected term which due to their maturity period as expiry, it was three years. The Company had no reason to believe future volatility over the expected remaining life of these common stock equivalents was likely to differ materially from historical volatility. Expected life was based on three years due to the expiry of maturity. The risk-free rate was based on the U.S. Treasury rate that corresponded to the expected term of the common stock equivalents. December 31, 2020 December 31, 2019 Stock Price $ 0.104 $ 0.285 Exercise Price $ 0.26 $ 1.00 Term (expected in years) 4.73 3.00 Volatility 259.2% 262.4% Annual Rate of Dividends 0.0% 0.0% Risk-Free Rate 0.18% 1.92% Stock Purchase Warrant The following table summarizes all warrant activity for the years ended December 31, 2020 and 2019. Weighted-Average Exercise Price Remaining Intrinsic Shares Per Share term value Outstanding, December 31, 2018 2,245,000 $ 0.57 1.05 years - Granted 425,000 $ 0.41 1.34 years - Exercised 250,000 $ 0.01 - - Expired - - - - Outstanding and Exercisable at December 31, 2019 2,420,000 $ 0.61 .73 years - Granted 2,550,000 $ 0.12 4.75 years - Exercised - - Expired (1,575,000) - - - Outstanding and Exercisable at December 31, 2020 3,395,000 $ 0.26 4.73 years - |
Note 13 - Commitments and Conti
Note 13 - Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 13 - Commitments and Contingencies | NOTE 13 – COMMITMENTS AND CONTINGENCIES Rental Payments under Non-cancelable Operating Leases The Company has a lease for warehouse and shipping space in Lenexa, Kansas which expires in January 2026. And an annually renewable lease for manufacturing and warehouse space in Chanute, Kansas. The following is a schedule, by year, of the future minimum rental payments under the lease: Year ended December 31, 2021 158,029 2022 72,638 2023 74,112 2024 75,362 2025 76,390 Subsequent 19,162 Total $ $475,693 Rent costs totaled approximately $159,120 and $121,992 for years ended December 31, 2020 and 2019, respectively. |
Note 14 - Subsequent Events
Note 14 - Subsequent Events | 12 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 14 - Subsequent Events | NOTE 14 – SUBSEQUENT EVENTS The Company evaluated all events that occurred after the balance sheet date of December 31, 2020 through the date the financial statements were issued and determined that there were the following subsequent events. Subsequent to December 31, 2020, the Company entered into a one-year promissory note dated January 6, 2021, in the amount of $40,000 paying 18% interest. Interest and principal are due at maturity. Subsequent to December 31, 2020, the Company received an equity investment of $50,000 on January 12, 2021, to purchase 833,333 shares of the Company’s common stock by Subscription Agreement at $0.06 per share.. Subsequent to December 31, 2020, the Company entered into a one-year promissory note dated March 4, 2021 in the amount of $50,000. The Company will pay monthly interest payments at 12% per annum to the holder of the note. A component of the note issued 600,000 shares of common stock to the note holder. Subsequent to December 31, 2020, the Company received an equity investment of $100,000 on March 5, 2021, to purchase 1,666,667 shares of the Company’s common stock by Subscription Agreement at $0.06 per share. On March 1, 2021, a related party advanced the Company $117,600 to make outstanding note payments. On March 10, 2021, the Company issued 280,000 shares of common stock to pay interest on an outstanding note. On March 10, 2021, the Company issued 310,000 shares of common stock to pay interest on an outstanding note. On March 24, 2021, the Company authorized the issuance of 2,500,000 shares of common stock to a consulting company controlled by an officer, as consideration of the termination of such consultant’s services and to relieve the Company from certain ongoing compensation commitments. Such shares will be issued only upon the amendment to the Company’s articles of incorporation to increase its authorized shares of common stock. On March 24, 2021, the Company authorized the issuance of 2,145,000 shares of common stock to its CEO and 2,145,000 shares of common stock to its President. 4,190,000 of such shares will be issued only upon the amendment to the Company’s articles of incorporation to increase its authorized shares of common stock Effective March 31, 2021, the Company entered into a forbearance agreement with a current debt holder, whereby the Company agreed to repay four notes owed to such holder with an initial payment of $100,000 and eight monthly installment payments totaling $173,187.50. On April 9, 2021, the Company received a $1,000,000 bridge loan from a current officer/director. As part of the bridge loan, the Company issued the officer/director a five-year warrant to purchase 2,000,000 shares of common stock at $0.10 per share and pledged 2,000,000 shares of common stock as security for the bridge loan. On April 9, 2021, the Company entered into two employment agreements with recently appointed officers, whereby it agreed to issue 8,750,000 shares of common stock to such officers. In addition, the Company entered into amendments to the current employment agreements with its CEO and President, whereby it agreed to issue 8,000,000 shares of common stock. All of these shares will be issued only upon the amendment to the Company’s articles of incorporation to increase its authorized shares of common stock. On April 18, 2021, the Company executed a $591,000 secured replacement promissory note with a current debt holder, whereby the Company agreed to consolidate and repay two notes owed to such holder with an initial payment of $100,000 and monthly installment payments for the balance of the note. On April 20, 2021, the Company issued 50,000 shares of common stock in return for services rendered. On April 21, 2021, the Company entered into a settlement agreement with a current debt holder, whereby the Company agreed to repay two notes and an advancement from such holder, including accrued interest at 8% per annum, with a payment of $639,955.64. On April 22, 2021, the Company entered into a settlement agreement with a current debt holder, whereby the Company agreed to repay the $151,687.97 balance owing on the note owed to such holder with a cash payment of $50,000 and the issuance of 2,000,000 shares of common stock, with a stated value of $100,687.97. On April 30, 2021, the Company received a $190,000 six-month loan from a current officer/director. |
Note 1 - Summary of Significa_2
Note 1 - Summary of Significant Accounting Policies: Nature of operations (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Nature of operations | Nature of operations The Company is developing branded products in the self-defense, safe storage and patriotic product areas that are promoted and sold using personal appearance, music, internet and television avenues. The CompanyÂ’s products will be under the American Rebel Brand and imprinted. |
Note 1 - Summary of Significa_3
Note 1 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Principles of Consolidation | Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and its majority-owned subsidiary. All significant intercompany accounts and transactions have been eliminated. |
Note 1 - Summary of Significa_4
Note 1 - Summary of Significant Accounting Policies: Year end (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Year end | Year end The CompanyÂ’s year-end is December 31. |
Note 1 - Summary of Significa_5
Note 1 - Summary of Significant Accounting Policies: Cash and cash equivalents (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Cash and cash equivalents | Cash and cash equivalents For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value. |
Note 1 - Summary of Significa_6
Note 1 - Summary of Significant Accounting Policies: Inventory and Inventory Deposits (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Inventory and Inventory Deposits | Inventory and Inventory Deposits Inventory consists of safes, backpacks, jackets and accessories manufactured to our design and held for resale and are carried at the lower of cost (First-in, First-out Method) or market value. The Company determines the estimate for the reserve for slow moving or obsolete inventories by regularly evaluating individual inventory levels, projected sales and current economic conditions. The Company also makes deposit payments on inventory to be manufactured that are carried separately until the goods are received into inventory. |
Note 1 - Summary of Significa_7
Note 1 - Summary of Significant Accounting Policies: Fixed assets and depreciation (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Fixed assets and depreciation | Fixed assets and depreciation Property and equipment are stated at cost net of accumulated depreciation. Additions and improvements are capitalized while ordinary maintenance and repair expenditures are charged to expense as incurred. Depreciation is recorded by the straight-line method over the estimated useful life of the asset, which ranges from five to seven years. |
Note 1 - Summary of Significa_8
Note 1 - Summary of Significant Accounting Policies: Revenue recognition (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Revenue recognition | Revenue recognition In accordance with ASC Topic 606, Revenue from Contracts with Customers ("ASC 606"), revenues are recognized when control of the promised goods or services is transferred to our clients, in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: 1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the company satisfies a performance obligation. We adopted this ASC on January 1, 2018. Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities within them. |
Note 1 - Summary of Significa_9
Note 1 - Summary of Significant Accounting Policies: Advertising costs (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Advertising costs | Advertising costs Advertising costs are expensed as incurred; Marketing costs incurred were $390,294 and $632,522 for the years ended December 31, 2020 and 2019, respectively. |
Note 1 - Summary of Signific_10
Note 1 - Summary of Significant Accounting Policies: Fair value of financial instruments (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Fair value of financial instruments | Fair value of financial instruments Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2020 and December 31, 2019, respectively. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, and accounts payable. Fair values were assumed to approximate carrying values for cash and payables because they are short-term in nature and their carrying amounts approximate fair values or they are payable on demand. Level 1: Level 2: FASB acknowledged that active markets for identical assets and liabilities are relatively uncommon and, even when they do exist, they may be too thin to provide reliable information. To deal with this shortage of direct data, the board provided a second level of inputs that can be applied in three situations. Level 3: If inputs from levels 1 and 2 are not available, the Financial Accounting Standards Board (the “FASB”) acknowledges that fair value measures of many assets and liabilities are less precise. The board describes Level 3 inputs as “unobservable,” and limits their use by saying they “shall be used to measure fair value to the extent that observable inputs are not available.” This category allows “for situations in which there is little, if any, market activity for the asset or liability at the measurement date”. Earlier in the standard, FASB explains that “observable inputs” are gathered from sources other than the reporting company and that they are expected to reflect assumptions made by market participants. |
Note 1 - Summary of Signific_11
Note 1 - Summary of Significant Accounting Policies: Stock-based compensation (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Stock-based compensation | Stock-based compensation The Company records stock-based compensation in accordance with the guidance in ASC Topic 505 and 718 which requires the Company to recognize expense related to the fair value of its employee stock option awards. This eliminates accounting for share-based compensation transactions using the intrinsic value and requires instead that such transactions be accounted for using a fair-value-based method. The Company recognizes the cost of all share-based awards on a graded vesting basis over the vesting period of the award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 718-10 and the conclusions reached by the FASB ASC 505-50. Costs are measured at the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by FASB ASC 505-50. In January 2018, the Company agreed to issue and subsequently issued a total of 500,000 shares of common stock as compensation for professional services to be performed during 2018. The common stock was valued at a price of $0.50 per share consistent with earlier sales of common stock by American Rebel, Inc. as well as the present conversion price of the CompanyÂ’s convertible debentures. In January, 2018, the Company issued 300,000 shares of common stock as compensation in settlement of professional services billed at $180,000. During January 2018, the Company recorded $157,483 in compensation expense, increased prepaid expense $31,251, and reduced Accrued expense $74,600 with the issuance of 466,667 shares of common stock. The common stock was valued at prices of $0.50 and $0.60 per share consistent with earlier sales of common stock by American Rebel, Inc. as well as the present conversion price of the CompanyÂ’s convertible debentures and negotiation with a vendor. During January 2019, the Company recorded $178,505 in compensation expense, increased prepaid expense $160,000, and increased Discount on debt $57,467 with the issuance of 400,000 shares of common stock and 175,000 warrants to purchase common stock. The common stock was valued at prices of $0.65 to $0.76 per share consistent with market prices at the date of the transaction. During September 2019, the Company recorded $3,432,000 in compensation expense and increased Discount on debt $819,500 with the issuance of 11,000,000 shares of common stock and 50,000 warrants to purchase common stock. The common stock was valued at prices of $0.70 to $0.30 per share consistent with market prices at the dates of the transactions. During October and November 2019, the Company recorded $330,000 in compensation expense and increased Discount on debt $86,000 with the issuance of 1,650,000 shares of common stock. The common stock was valued at prices of $0.22 to $0.30 per share consistent with market prices at the dates of the transactions. In February 2020, the Company issued 1,200,000 shares of its Common Stock to pay professional and consulting fees. Total fair value of $240,000 was recorded as an expense. In June 2020, the Company issued 810,000 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $95,000 was recorded as an expense. In August 2020, the Company issued 4,839,871 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $489,462 was recorded as an expense. In October 2020, the Company issued 6,410,000 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $553,820 was recorded as an expense. During May 2020, the Company issued 70,000 shares of its Common Stock in exchange for a debt reduction of $7,000. |
Note 1 - Summary of Signific_12
Note 1 - Summary of Significant Accounting Policies: Earnings per share (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Earnings per share | Earnings per share The Company follows ASC Topic 260 to account for earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. |
Note 1 - Summary of Signific_13
Note 1 - Summary of Significant Accounting Policies: Income taxes (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Income taxes | Income taxes The Company follows ASC Topic 740 for recording provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expense or benefit is based on the changes in the asset or liability for each period. If available evidence suggests that it is more likely than not that some portion or the entire deferred tax asset will not be realized, a valuation allowance is required to reduce the deferred tax asset to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income tax in the period of change. Deferred income tax may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC Topic 740 only allows the recognition of tax benefits that have a greater than fifty percent likelihood of being sustained upon examination by taxing authorities. As of December 31, 2020 and December 31, 2019, the Company reviewed its tax positions and determined there were no outstanding, or retroactive tax positions with less than a 50% likelihood of being sustained upon examination by the taxing authorities, therefore this standard has not had a material effect on the Company. The Company does not anticipate any significant changes to its total unrecognized tax benefits within the next 12 months. The Company classifies tax-related penalties and net interest as income tax expense. For the years ended December 31, 2020 and 2019, respectively, no income tax expense has been recorded. |
Note 1 - Summary of Signific_14
Note 1 - Summary of Significant Accounting Policies: Use of estimates (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Use of estimates | Use of estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates. |
Note 1 - Summary of Signific_15
Note 1 - Summary of Significant Accounting Policies: Recent pronouncements (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Recent pronouncements | Recent pronouncements The Company evaluated recent accounting pronouncements through December 31, 2020 and believes that none have a material effect on the CompanyÂ’s financial statements. |
Note 1 - Summary of Signific_16
Note 1 - Summary of Significant Accounting Policies: Concentration Risk (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Policies | |
Concentration Risk | Concentration Risk In 2020, the Company purchased a substantial portion (over 20%) of inventory from two third-party vendors. As of December 31, 2020, the net amount due to the vendors (accounts payable and accrued expense) was $0. In 2019, the Company purchased substantially all of inventory from one third-party vendor. As of December 31, 2019, the net amount due to the vendor (accounts payable and accrued expense) was $221,920. The loss of these manufacturing vendor relationships could have a material effect on the Company, but the Company believes there are numerous other suppliers that could be substituted should these suppliers become unavailable or non-competitive. |
Note 1 - Summary of Signific_17
Note 1 - Summary of Significant Accounting Policies: Right of Use Assets and Lease Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Right of Use Assets and Lease Liabilities | Right of Use Assets and Lease Liabilities In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The standard requires lessees to recognize almost all leases on the balance sheet as a Right-of-Use (“ROU”) asset and a lease liability and requires leases to be classified as either an operating or a finance type lease. The standard excludes leases of intangible assets or inventory. The standard became effective for the Company beginning January 1, 2019. The Company adopted ASC 842 using the modified retrospective approach, by applying the new standard to all leases existing at the date of initial application. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under ASC 842, while prior period amounts have not been adjusted and continue to be reported in accordance with our historical accounting under ASC 840. The Company elected the package of practical expedients permitted under the standard, which also allowed the Company to carry forward historical lease classifications. The Company also elected the practical expedient related to treating lease and non-lease components as a single lease component for all equipment leases as well as electing a policy exclusion permitting leases with an original lease term of less than one year to be excluded from the ROU assets and lease liabilities. Under ASC 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company estimated the incremental borrowing rate in determining the present value of lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’ lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating leases are included in operating lease Right-of-Use assets and operating lease liabilities, current and non-current, on the Company's consolidated balance sheets. |
Note 3 - Inventory and Deposi_2
Note 3 - Inventory and Deposits: Schedule of Inventory (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of Inventory | December 31, December 31, 2020 2019 Inventory - Finished goods $ 681,709 $ 805,845 Inventory deposits 141,164 91,641 822,873 897,486 Less: Reserve for excess and obsolete - - Net inventory and deposits $ 822,873 $ 897,486 |
Note 4 - Property and Equipme_2
Note 4 - Property and Equipment: Schedule of Property, Plant and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of Property, Plant and Equipment | Property and equipment includes the following: December 31, December 31, 2020 2019 Marketing equipment $ 32,261 $ 32,261 Vehicles 277,886 277,886 310,147 310,147 Less: Accumulated depreciation (304,881) (243,157) Net property and equipment $ 5,266 $ 66,990 |
Note 6 - Notes Payable - Non-_2
Note 6 - Notes Payable - Non-related Parties: Schedule of Notes Payable to Related Parties (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of Notes Payable to Related Parties | December 31, December 31, 2020 2019 Loan secured by a tour bus, payable in monthly payments of $2,710 including interest at 12% per annum through July 2020 when the remaining balance is payable. $ 15,649 $ 25,746 Total recorded as current liability $ 15,649 $ 25,746 |
Note 7 - Notes Payable - Work_2
Note 7 - Notes Payable - Working Capital: NOTE PAYABLE SCHEDULE (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
NOTE PAYABLE SCHEDULE | NOTE PAYABLE SCHEDULE Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at December 31, 2020 Balance at December 31, 2019 Note Payable (a) $200,000 3/4/2018 12/31/2018 12% $200,000 $200,000 Note Payable (b) $7,000 1/9/2019 $9,073 $8,689 Note Payable (c) $400,000 11/1/2018 5/1/2019 12% $400,000 $400,000 Note Payable (d) $300,000 12/31/2018 12/31/2020 $300,000 Note Payable (e) $55,000 1/14/2019 3/15/2019 15% $30,000 $30,000 Note Payable (f) $150,000 3/1/2019 9/30/2019 20% $0 $0 Note Payable (g) $450,000 5/1/2019 5/1/2020 18% $0 $450,000 Note Payable (h) $180,000 7/5/2019 1/1/2020 18% $0 $180,000 Note Payable (i) $180,000 7/15/2019 1/11/2020 18% $0 $180,000 Note Payable (j) $225,000 8/22/2019 3/31/2020 $225,000 $165,000 Note Payable (k) $180,000 8/26/2019 2/22/2020 18% $0 $180,000 Note Payable (l) $180,000 9/5/2019 3/3/2020 18% $0 $180,000 Note Payable (m) $90,000 9/13/2019 3/11/2020 18% $0 $90,000 Note Payable (n) $180,000 9/13/2019 3/11/2020 18% $0 $180,000 Note Payable (o) $90,000 9/23/2019 3/21/2020 18% $0 $90,000 Note Payable (p) $150,000 9/30/2019 3/31/2020 20% $0 $150,000 Note Payable (q) $180,000 10/15/2019 4/12/2020 18% $95,000 $180,000 Note Payable (r) $180,000 11/5/2019 5/3/2020 18% $0 $180,000 Note Payable (s) $90,000 11/12/2019 5/10/2020 18% $0 $90,000 Note Payable (t) $100,000 11/19/2019 11/19/2020 18% $0 $50,000 Note Payable (u) $75,000 11/20/2019 5/20/2020 16% $0 $75,000 Note Payable (v) $455,670 12/17/2019 6/4/2022 12% $408,875 $455,670 Note Payable (w) $134,386 12/20/2019 $134,386 Note Payable (x) 12/31/2019 $12,219 $17,400 Note Payable (y) $201,000 1/30/2020 6/1/2020 12% $183,000 Note Payable (z) $125,000 1/31/2020 1/31/2021 7.5% $0 Note Payable (aa) $225,000 2/14/2020 1/14/2021 25% $18,750 Note Payable (ab) $90,000 2/18/2020 2/18/2021 18% $0 Note Payable (ac) $180,000 2/20/2020 2/20/2021 18% $0 Note Payable (ad) $200,000 3/6/2020 7/6/2021 12% $200,000 Note Payable (ae) $722,422 3/10/2020 2/8/2024 11.5% $679,609 Note Payable (af) $90,000 3/11/2020 9/11/2020 18% $0 Note Payable (ag) $300,000 3/26/2020 3/26/2021 6% $300,000 Note Payable (ah) $150,000 4/1/2020 10/1/2020 20% $0 Note Payable (ai) $8,000 4/15/2020 5/15/2021 $8,000 Note Payable (aj) $18,343 4/15/2020 5/15/2021 $18,343 Note Payable (ak) $180,000 4/25/2020 10/25/2020 18% $0 Note Payable (al) $450,000 5/1/2020 10/31/2020 18% $0 Note Payable (bn) $100,000 5/20/2020 11/20/2020 18% $0 Note Payable (am) $100,000 6/10/2020 12/10/2020 $100,000 Note Payable (an) $75,000 6/15/2020 6/15/2021 18% $75,000 Note Payable (ao) $101,000 6/18/2020 12/18/2020 $101,000 Note Payable (ap) $50,000 6/29/2020 9/29/2020 $0 Note Payable (aq) $102,000 7/3/2020 10/3/2020 $72,188 Note Payable (ar) $150,000 7/31/2020 7/31/2021 12% $0 Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at December 31, 2020 Balance at December 31, 2019 Note Payable (as) $150,000 8/5/2020 8/5/2021 12% $134,400 Note Payable (at) $350,000 9/3/2020 9/3/2021 12% $392,000 Note Payable (au) $100,000 9/10/2020 9/10/2021 12% $100,000 Note Payable (av) $250,000 10/1/2020 1/2/2021 8% $250,000 Note Payable (aw) $100,000 10/6/2020 10/6/2021 12% $100,000 Note Payable (ax) $200,000 10/13/2020 10/13/2021 12% $200,000 Note Payable (ay) $250,000 10/21/2020 4/21/2021 8% $250,000 Note Payable (az) $450,000 11/01/2020 4/30/2021 20% $450,000 Note Payable (ba) $150,000 11/1/2020 4/30/2021 20% $150,000 Note Payable (bb) $118,049 11/19/2020 11/19/2021 18% $118,049 Note Payable (bc) $109,200 11/20/2020 5/21/2021 18% $109,200 Note Payable (bd) $60,000 12/16/2020 12/16/2021 18% $60,000 Note Payable (be) $40,000 1/6/2021 1/7/2022 18% Note Payable (bf) $117,600 3/1/2021 4/21/2021 8% Note Payable (bg) $50,000 3/4/2021 3/4/2022 12% Note Payable (bh) $273,187 3/31/2021 12/1/2021 Note Payable (bi) $1,000,000 4/9/2021 10/6/2021 8% Note Payable (bj) $591,000 4/18/2021 9/1/2023 Note Payable (bk) $639,956 4/21/2021 4/22/2021 8% Note Payable (bl) $151,688 4/22/2021 5/1/2021 Note Payable (bm) $190,000 4/30/2021 10/30/2021 Unamortized Discount $(777,610) $(370,584) Total $4,672,096 $3,595,561 (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) (n) (o) (p) (q) (r) (s) (t) (u) (v) (w) (x) (y) (z) (aa) (ab) (ac) (ad) (ae) (af) (ag) (ah) (ai) (aj) (ak) (al) (am) (an) (ao) (ap) (aq) (ar) (as) (at) (au) (av) (aw) (ax) (ay) (az) (ba) (bb) (bc) (bd) (be) (bf) (bg) (bh) (bi) (bj) (bk) (bl) (bm) (bn) |
Note 10 - Income Taxes_ Schedul
Note 10 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of Deferred Tax Assets and Liabilities | December 31, 2020 December 31, 2019, Deferred tax asset: Net operating loss carryforward $ 4,382,850 $ 3,126,823 Total deferred tax asset 4,382,850 3,126,823 Less: Valuation allowance (4,382,850) (3,126,823) Net deferred tax asset $ - $ - |
Note 10 - Income Taxes_ Sched_2
Note 10 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of Effective Income Tax Rate Reconciliation | Federal statutory rate (21.0)% State taxes, net of federal benefit (0.00)% Change in valuation allowance 21.0% Effective tax rate 0.0% |
Note 12 - Warrants and Options_
Note 12 - Warrants and Options: Schedule of Fair Value Measurement (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of Fair Value Measurement | December 31, 2020 December 31, 2019 Stock Price $ 0.104 $ 0.285 Exercise Price $ 0.26 $ 1.00 Term (expected in years) 4.73 3.00 Volatility 259.2% 262.4% Annual Rate of Dividends 0.0% 0.0% Risk-Free Rate 0.18% 1.92% |
Note 12 - Warrants and Option_2
Note 12 - Warrants and Options: Schedule of Warrant Activity (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of Warrant Activity | Weighted-Average Exercise Price Remaining Intrinsic Shares Per Share term value Outstanding, December 31, 2018 2,245,000 $ 0.57 1.05 years - Granted 425,000 $ 0.41 1.34 years - Exercised 250,000 $ 0.01 - - Expired - - - - Outstanding and Exercisable at December 31, 2019 2,420,000 $ 0.61 .73 years - Granted 2,550,000 $ 0.12 4.75 years - Exercised - - Expired (1,575,000) - - - Outstanding and Exercisable at December 31, 2020 3,395,000 $ 0.26 4.73 years - |
Note 13 - Commitments and Con_2
Note 13 - Commitments and Contingencies: Schedule of future minimum rental payments (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Tables/Schedules | |
Schedule of future minimum rental payments | Year ended December 31, 2021 158,029 2022 72,638 2023 74,112 2024 75,362 2025 76,390 Subsequent 19,162 Total $ $475,693 |
Note 1 - Summary of Signific_18
Note 1 - Summary of Significant Accounting Policies (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Details | |
Entity Incorporation, Date of Incorporation | Dec. 15, 2014 |
Entity Incorporation, State or Country Code | NV |
Note 2 - Going Concern (Details
Note 2 - Going Concern (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Details | ||
Net income (loss) | $ (5,981,082) | $ (7,602,072) |
Accumulated deficit | (20,870,713) | (14,889,631) |
Working Capital Deficit | $ 4,726,654 | $ 2,812,957 |
Note 3 - Inventory and Deposi_3
Note 3 - Inventory and Deposits: Schedule of Inventory (Details) - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Details | ||
Inventory - Finished goods | $ 681,709 | $ 805,845 |
Inventory deposits | 141,164 | 91,641 |
Less: Reserve for excess and obsolete | 0 | 0 |
Net inventory and deposits | $ 822,873 | $ 897,486 |
Note 4 - Property and Equipme_3
Note 4 - Property and Equipment: Schedule of Property, Plant and Equipment (Details) - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Details | ||
Marketing equipment | $ 32,261 | $ 32,261 |
Vehicles | 277,886 | 277,886 |
Less: Accumulated depreciation | (304,881) | (243,157) |
Net property and equipment | $ 5,266 | $ 66,990 |
Note 4 - Property and Equipme_4
Note 4 - Property and Equipment (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Details | ||
Depreciation expense | $ 61,724 | $ 62,028 |
Note 5 - Related Party Note P_2
Note 5 - Related Party Note Payable and Related Party Transactions (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
For the year ended December 31, 2016 | ||
Debt Instrument, Description | Company received loans from its sole officer and director at the time totaling $221,155 | |
Long-term Debt | $ 4,526 | $ 4,496 |
During the year ended December 31, 2018 | ||
Debt Instrument, Description | Company entered into several convertible debt instruments with stockholders | |
During the year ended December 31, 2016 | ||
Debt Instrument, Description | Company acquired three vehicles from various related parties and assumed the debt secured by each one of the vehicles. |
Note 6 - Notes Payable - Non-_3
Note 6 - Notes Payable - Non-related Parties: Schedule of Notes Payable to Related Parties (Details) - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Details | ||
Loan secured by a tour bus | $ 15,649 | $ 25,746 |
Total recorded as current liability | $ 15,649 | $ 25,746 |
Note 7 - Notes Payable - Work_3
Note 7 - Notes Payable - Working Capital (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Common Stock, Shares, Issued | 72,807,979 | 43,062,058 |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
On July 6, 2017 | ||
Debt Instrument, Issuance Date | Jul. 6, 2017 | |
Debt Instrument, Issuer | Company’s wholly-owned operating subsidiary | |
Debt Instrument, Description | secured promissory note | |
Debt Instrument, Face Amount | $ 250,000 | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |
Debt Instrument, Collateral | notes are secured by a pledge of certain of the Company’s current inventory and the chief executive officer’s personal guaranty | |
Debt Instrument, Payment Terms | payments equal to 75-100% of current sales | |
Common Stock, Shares, Issued | 250,000 | |
Common Stock, Par or Stated Value Per Share | $ 0.50 | |
Common Stock, Value, Subscriptions | $ 125,000 | |
Long-term Debt | $ 4,672,096 | $ 3,595,561 |
In April, 2018 | ||
Debt Instrument, Issuer | Company’s wholly-owned operating subsidiary | |
Debt Instrument, Description | additional notes | |
Debt Instrument, Face Amount | $ 250,000 | |
In October and December, 2018 | ||
Debt Instrument, Issuer | Company’s wholly-owned operating subsidiary | |
Debt Instrument, Description | additional notes | |
Debt Instrument, Face Amount | $ 425,000 |
Note 8 - Convertible Debentur_2
Note 8 - Convertible Debenture, Related Party (Details) | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Convertible Debenture 1 | |
Debt Instrument, Issuer | Company |
Debt Instrument, Description | convertible debentures |
Debt Instrument, Face Amount | $ 2,405,000 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Debt Instrument, Payment Terms | payable in common stock at maturity |
Debt Instrument, Convertible, Terms of Conversion Feature | may be converted into common stock at a price of $0.50 per share after the passage of 181 days |
Proceeds from Loans | $ 2,405,000 |
Long-term Debt | $ 345,000 |
Convertible Debenture 2 | |
Debt Instrument, Issuer | Company |
Debt Instrument, Description | convertible debt instruments |
Debt Instrument, Face Amount | $ 270,000 |
Note 10 - Income Taxes_ Sched_3
Note 10 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Deferred tax asset: | ||
Net operating loss carryforward | $ 4,382,850 | $ 3,126,823 |
Less: Valuation allowance | (4,382,850) | (3,126,823) |
Net deferred tax asset | 0 | 0 |
Total deferred tax asset | $ 4,382,850 | $ 3,126,823 |
Note 10 - Income Taxes_ Sched_4
Note 10 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) | 12 Months Ended |
Dec. 31, 2019 | |
Details | |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | (21.00%) |
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | (0.00%) |
Change in valuation allowance | 21.00% |
Effective Income Tax Rate Reconciliation, Percent | 0.00% |
Note 11 - Share Capital (Detail
Note 11 - Share Capital (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Shares Authorized | 1,000,000 | 1,000,000 |
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares, Issued | 72,807,979 | 43,062,058 |
Common Stock, Shares, Outstanding | 72,807,979 | 43,062,058 |
On December 15, 2014 | ||
Common Stock, Par or Stated Value Per Share | $ 0.001 | |
Common Stock, Shares, Issued | 6,000,000 | |
On January 15, 2015 | ||
Common Stock, Par or Stated Value Per Share | $ 0.001 | |
Common Stock, Shares, Issued | 3,000,000 | |
On October 14, 2015 | ||
Common Stock, Shares, Issued | 17,421,000 | |
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited | 9,000,000 | |
During June 2017 | ||
Common Stock, Shares, Issued | 2,800,000 | |
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited | 9,000,000 | |
On July 6, 2017 | ||
Common Stock, Par or Stated Value Per Share | $ 0.50 | |
Common Stock, Shares, Issued | 250,000 | |
Sale of Stock, Transaction Date | Jul. 6, 2017 | |
Shares, Issued | 250,000 | |
On August 6, 2017 | ||
Sale of Stock, Transaction Date | Aug. 6, 2017 | |
Shares, Issued | 100,000 | |
In January 2018 | ||
Sale of Stock, Description of Transaction | Company’s wholly owned subsidiary completed an agreement to acquire professional services during 2018 in exchange for 500,000 shares of the Company’s common stock | |
January 2018 | ||
Sale of Stock, Description of Transaction | Company issued 300,000 shares of common stock to settle a liability for professional services | |
Stock Issued During Period, Shares, New Issues | 300,000 | |
In January 2019 | ||
Sale of Stock, Description of Transaction | Company issued a 30 day warrant to purchase 250,000 shares of its common stock at a price of $0.01 per share to pay consulting fees | |
January 2019 | ||
Sale of Stock, Description of Transaction | Company’s wholly-owned operating subsidiary completed the sale of a secured promissory note in the principal amount of $300,000 | |
In May 2019 | ||
Sale of Stock, Description of Transaction | Company identified 50,000 shares of common stock in its subsidiary that had been awarded at date of incorporation but not recorded | |
In September 2019 | ||
Sale of Stock, Description of Transaction | Company issued 1,400,000 shares of its common stock in conjunction with notes payable | |
Stock Issued During Period, Shares, New Issues | 1,400,000 | |
September 2019 | ||
Sale of Stock, Description of Transaction | Company issued 9,700,000 shares of its common stock to pay professional and consulting fees | |
Stock Issued During Period, Shares, New Issues | 9,700,000 | |
In November 2019 | ||
Sale of Stock, Description of Transaction | Company issued 150,000 shares of its common stock in conjunction with notes payable | |
Stock Issued During Period, Shares, New Issues | 150,000 | |
In December 2019 | ||
Sale of Stock, Description of Transaction | Company issued 1,500,000 shares of its common stock to pay professional and consulting fees | |
Stock Issued During Period, Shares, New Issues | 1,500,000 |
Note 12 - Warrants and Options
Note 12 - Warrants and Options (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Warrants or rights, date of issue | Jun. 19, 2017 | |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 500,000 | |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.50 | |
Class of Warrant or Right, Outstanding | 2,245,000 | 3,395,000 |
Since September 16, 2016 | ||
Sale of Stock, Description of Transaction | Company issued three-year warrants to purchase 2,405,000 shares of the Company’s common stock | |
Sale of Stock, Price Per Share | $ 1 |
Note 12 - Warrants and Option_3
Note 12 - Warrants and Options: Schedule of Fair Value Measurement (Details) | 12 Months Ended | |
Dec. 31, 2020$ / shares | Dec. 31, 2019$ / shares | |
Details | ||
Stock Price | $ 0.104 | $ 0.285 |
Exercise Price | $ 0.26 | $ 1 |
Term (expected in years) | 4 years 8 months 23 days | 3 years |
Volatility | 2.5920 | 2.6240 |
Annual Rate of Dividends | 0 | 0 |
Risk-Free Rate | 0.0018 | 0.0192 |
Note 12 - Warrants and Option_4
Note 12 - Warrants and Options: Schedule of Warrant Activity (Details) - USD ($) | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2020 | Dec. 31, 2019 |
Details | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance | 2,420,000 | 2,245,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance | $ 0.61 | $ 0.57 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 8 months 23 days | 1 year 18 days | 4 years 8 months 23 days | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 0 | $ 0 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 2,550,000 | 425,000 | ||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 0.12 | $ 0.41 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 250,000 | |||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ 0.01 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | (1,575,000) | 0 | ||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | $ 0 | $ 0 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 2,420,000 | 2,245,000 | 3,395,000 | 2,420,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance | $ 0.61 | $ 0.57 | $ 0.26 | $ 0.61 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 0 | $ 0 | $ 0 | $ 0 |
Note 13 - Commitments and Con_3
Note 13 - Commitments and Contingencies: Schedule of future minimum rental payments (Details) | Dec. 31, 2020USD ($) |
Details | |
Operating Leases, Future Minimum Payments, Next Rolling Twelve Months | $ 158,029 |
Operating Leases, Future Minimum Payments, Due in Rolling Year Two | 72,638 |
Operating Leases, Future Minimum Payments, Due in Rolling Year Three | 74,112 |
Operating Leases, Future Minimum Payments, Due in Rolling Year Four | 75,362 |
Operating Leases, Future Minimum Payments, Due in Rolling Year Five | 76,390 |
Operating Leases, Future Minimum Payments, Due in Rolling after Year Five | 19,162 |
Operating Leases, Future Minimum Payments Due | $ 475,693 |
Note 14 - Subsequent Events (De
Note 14 - Subsequent Events (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Event #1 | |
Subsequent Event, Description | Company entered into a one-year promissory note |
Subsequent Event, Date | Jan. 6, 2021 |
Event #2 | |
Subsequent Event, Description | Company received an equity investment of $50,000 |
Subsequent Event, Date | Jan. 12, 2021 |
Event #3 | |
Subsequent Event, Description | Company entered into a one-year promissory note |
Subsequent Event, Date | Mar. 4, 2021 |
Event #4 | |
Subsequent Event, Description | Company received an equity investment of $100,000 |
Subsequent Event, Date | Mar. 5, 2021 |
Event #5 | |
Subsequent Event, Description | a related party advanced the Company $117,600 |
Subsequent Event, Date | Mar. 1, 2021 |
Event #6 | |
Subsequent Event, Description | Company issued 280,000 shares of common stock |
Subsequent Event, Date | Mar. 10, 2021 |
Event #7 | |
Subsequent Event, Description | Company issued 310,000 shares of common stock |
Subsequent Event, Date | Mar. 10, 2021 |
Event #8 | |
Subsequent Event, Description | Company authorized the issuance of 2,500,000 shares of common stock |
Subsequent Event, Date | Mar. 24, 2021 |
Event #9 | |
Subsequent Event, Description | Company authorized the issuance of 2,145,000 shares of common stock |
Subsequent Event, Date | Mar. 24, 2021 |
Event #10 | |
Subsequent Event, Description | Company entered into a forbearance agreement with a current debt holder |
Subsequent Event, Date | Mar. 31, 2021 |
Event #11 | |
Subsequent Event, Description | Company received a $1,000,000 bridge loan from a current officer/director |
Subsequent Event, Date | Apr. 9, 2021 |
Event #12 | |
Subsequent Event, Description | Company entered into two employment agreements |
Subsequent Event, Date | Apr. 9, 2021 |
Event #13 | |
Subsequent Event, Description | Company executed a $591,000 secured replacement promissory note |
Subsequent Event, Date | Apr. 18, 2021 |
Event #14 | |
Subsequent Event, Description | Company issued 50,000 shares of common stock |
Subsequent Event, Date | Apr. 20, 2021 |
Event #15 | |
Subsequent Event, Description | Company entered into a settlement agreement with a current debt holder |
Subsequent Event, Date | Apr. 21, 2021 |
Event #16 | |
Subsequent Event, Description | Company entered into a settlement agreement with a current debt holder |
Subsequent Event, Date | Apr. 22, 2021 |
Event #17 | |
Subsequent Event, Description | Company received a $190,000 six-month loan from a current officer/director |
Subsequent Event, Date | Apr. 30, 2021 |